Viewing Study NCT03055858



Ignite Creation Date: 2024-05-06 @ 9:43 AM
Last Modification Date: 2024-10-26 @ 12:18 PM
Study NCT ID: NCT03055858
Status: COMPLETED
Last Update Posted: 2022-12-06
First Post: 2017-02-14

Brief Title: AMPLATZER Duct Occluder II Additional Sizes
Sponsor: Abbott Medical Devices
Organization: Abbott Medical Devices

Study Overview

Official Title: AMPLATZER Duct Occluder II Additional Sizes Clinical Study
Status: COMPLETED
Status Verified Date: 2022-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ADO II AS
Brief Summary: The ADO II AS Study is a single arm prospective multicenter nonrandomized clinical investigation to characterize the safety and effectiveness of the ADO II AS device in patients with a patent ductus arteriosus PDA Subjects will be implanted with the ADO II AS device using a transcatheter femoral vessel approach under fluoroscopic and echocardiographic guidance

To account for subject dropout up to 50 subjects will be enrolled in this clinical investigation Up to an additional 150 subjects may be enrolled under continued access The clinical investigation will be conducted at up to 10 centers in the United States

Subjects participating in this clinical investigation will be followed for 3 years The expected duration of enrollment is 18 months The total duration of the clinical investigation is expected to be 45 years
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: True
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None